United Nations Industrial Development Organization (UNIDO) / unido-activity-senegal
Strengthening the production of vaccines and pharmaceuticals in Senegal
XM-DAC-41123-PROJECT-230283
USD 1.16mdeclared budget
USD 1.13mdisbursed and spent, 110 of 220 transactions
Implementationstatus
30 Nov 2026planned end
Budget over time
- Reporting organisation
- United Nations Industrial Development Organization
- Start
- 01 Dec 2023 (planned)
- Countries
- —
- Sectors
- 321 · OECD DAC 3-digit
- Funded by
- GERMANY
- Participating
- United Nations Industrial Development Organization (implementing); GERMANY (funding)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-02 02:28 UTC
Changes
- 2026-10-02Transaction rewritten+2 more
Transaction on 2026-08-31 rewritten USD 694.02 → USD 694.88
- Transaction rewritten: Transaction on 2026-08-31 rewritten USD 161.8 → USD 162.35
- Transactions added: 6 transactions added, USD 9,929
Strengthening the production of vaccines and pharmaceuticals in Senegal · compare 2d51fee1 → d0b1554c
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2024-01-01 → 2024-12-31 | original | USD 411k | current |
| 2025-01-01 → 2025-12-31 | original | USD 387k | current |
| 2026-01-01 → 2026-12-31 | original | USD 362k | current |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2024-01-31 | Incoming funds | USD 397k | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-01-31 | Expenditure | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-01-31 | Incoming funds | USD 81k | Output 1.3 Management | ||
| 2024-01-31 | Expenditure | USD 29k | Output 1.3 Management | ||
| 2024-01-31 | Incoming funds | USD 19k | Output 1.4 Monitoring and Evaluation | ||
| 2024-01-31 | Expenditure | USD 0 | Output 1.4 Monitoring and Evaluation | ||
| 2024-02-29 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-02-29 | Expenditure | USD 23k | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-02-29 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-02-29 | Expenditure | USD 323 | Output 1.3 Management | ||
| 2024-03-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-03-31 | Expenditure | USD 55k | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-03-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-03-31 | Expenditure | USD 3,757 | Output 1.3 Management | ||
| 2024-04-30 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-04-30 | Expenditure | USD 36k | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-04-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-04-30 | Expenditure | USD 6,170 | Output 1.3 Management | ||
| 2024-05-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-05-31 | Expenditure | USD 4,470 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-05-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-05-31 | Expenditure | USD -1,550 | Output 1.3 Management | ||
| 2024-06-30 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-06-30 | Expenditure | USD 64k | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-06-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-06-30 | Expenditure | USD 74 | Output 1.3 Management | ||
| 2024-07-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-07-31 | Expenditure | USD 12k | Output 1.3 Management | ||
| 2024-07-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-07-31 | Expenditure | USD -6,081 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-08-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-08-31 | Expenditure | USD 188 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-08-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-08-31 | Expenditure | USD 8,349 | Output 1.3 Management | ||
| 2024-09-30 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-09-30 | Expenditure | USD 98k | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-09-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-09-30 | Expenditure | USD 11k | Output 1.3 Management | ||
| 2024-10-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-10-31 | Expenditure | USD 7,877 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-10-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-10-31 | Expenditure | USD 4,562 | Output 1.3 Management | ||
| 2024-11-30 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-11-30 | Expenditure | USD 33k | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-11-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2024-11-30 | Expenditure | USD -481 | Output 1.3 Management | ||
| 2024-12-31 | Incoming funds | USD 17k | Output 1.4 Monitoring and Evaluation | ||
| 2024-12-31 | Expenditure | USD 0 | Output 1.4 Monitoring and Evaluation | ||
| 2024-12-31 | Incoming funds | USD 81k | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-12-31 | Expenditure | USD 9,363 | Output 1.1: Pharmaceutical ecosystem | ||
| 2024-12-31 | Incoming funds | USD 77k | Output 1.3 Management | ||
| 2024-12-31 | Expenditure | USD 3,858 | Output 1.3 Management | ||
| 2024-12-31 | Incoming funds | USD 211k | Output 1.2: Enhanced manufacturing | ||
| 2024-12-31 | Expenditure | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-01-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-01-31 | Expenditure | USD 27k | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-01-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-01-31 | Expenditure | USD 4,820 | Output 1.3 Management | ||
| 2025-01-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-01-31 | Expenditure | USD 85k | Output 1.2: Enhanced manufacturing | ||
| 2025-02-28 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-02-28 | Expenditure | USD 36k | Output 1.2: Enhanced manufacturing | ||
| 2025-02-28 | Incoming funds | USD -146 | Output 1.3 Management | ||
| 2025-02-28 | Expenditure | USD 46k | Output 1.3 Management | ||
| 2025-02-28 | Incoming funds | USD -1,194 | Output 1.4 Monitoring and Evaluation | ||
| 2025-02-28 | Expenditure | USD 0 | Output 1.4 Monitoring and Evaluation | ||
| 2025-02-28 | Incoming funds | USD -3,998 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-02-28 | Expenditure | USD 51k | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-03-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-03-31 | Expenditure | USD -618 | Output 1.2: Enhanced manufacturing | ||
| 2025-03-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-03-31 | Expenditure | USD 308 | Output 1.3 Management | ||
| 2025-03-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-03-31 | Expenditure | USD 136 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-04-30 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-04-30 | Expenditure | USD 14k | Output 1.2: Enhanced manufacturing | ||
| 2025-04-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-04-30 | Expenditure | USD 2,209 | Output 1.3 Management | ||
| 2025-04-30 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-04-30 | Expenditure | USD 1,036 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-05-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-05-31 | Expenditure | USD 6,934 | Output 1.2: Enhanced manufacturing | ||
| 2025-05-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-05-31 | Expenditure | USD 1,643 | Output 1.3 Management | ||
| 2025-05-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-05-31 | Expenditure | USD 1,750 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-06-30 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-06-30 | Expenditure | USD 29k | Output 1.2: Enhanced manufacturing | ||
| 2025-06-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-06-30 | Expenditure | USD 8,724 | Output 1.3 Management | ||
| 2025-06-30 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-06-30 | Expenditure | USD 13k | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-07-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-07-31 | Expenditure | USD 2,343 | Output 1.3 Management | ||
| 2025-07-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-07-31 | Expenditure | USD 1,380 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-07-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-07-31 | Expenditure | USD -2,369 | Output 1.2: Enhanced manufacturing | ||
| 2025-08-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-08-31 | Expenditure | USD 837 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-08-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-08-31 | Expenditure | USD 38 | Output 1.2: Enhanced manufacturing | ||
| 2025-08-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-08-31 | Expenditure | USD 7,438 | Output 1.3 Management | ||
| 2025-09-30 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-09-30 | Expenditure | USD 832 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-09-30 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-09-30 | Expenditure | USD 12k | Output 1.2: Enhanced manufacturing | ||
| 2025-09-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-09-30 | Expenditure | USD 2,030 | Output 1.3 Management | ||
| 2025-10-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-10-31 | Expenditure | USD 1,375 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-10-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-10-31 | Expenditure | USD 32k | Output 1.2: Enhanced manufacturing | ||
| 2025-10-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-10-31 | Expenditure | USD 2,225 | Output 1.3 Management | ||
| 2025-11-30 | Incoming funds | USD 123k | Output 2.1 Strengthened Coordination an | ||
| 2025-11-30 | Expenditure | USD 3,741 | Output 2.1 Strengthened Coordination an | ||
| 2025-11-30 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-11-30 | Expenditure | USD 15k | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-11-30 | Incoming funds | USD 117k | Output 2.2 Building Capacity for industr | ||
| 2025-11-30 | Expenditure | USD 3,809 | Output 2.2 Building Capacity for industr | ||
| 2025-11-30 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-11-30 | Expenditure | USD 785 | Output 1.2: Enhanced manufacturing | ||
| 2025-11-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-11-30 | Expenditure | USD 878 | Output 1.3 Management | ||
| 2025-12-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-12-31 | Expenditure | USD 220 | Output 1.1: Pharmaceutical ecosystem | ||
| 2025-12-31 | Incoming funds | USD 0 | Output 2.1 Strengthened Coordination an | ||
| 2025-12-31 | Expenditure | USD 230 | Output 2.1 Strengthened Coordination an | ||
| 2025-12-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2025-12-31 | Expenditure | USD -761 | Output 1.2: Enhanced manufacturing | ||
| 2025-12-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2025-12-31 | Expenditure | USD 525 | Output 1.3 Management | ||
| 2025-12-31 | Incoming funds | USD 0 | Output 2.2 Building Capacity for industr | ||
| 2025-12-31 | Expenditure | USD 233 | Output 2.2 Building Capacity for industr | ||
| 2026-01-31 | Incoming funds | USD 810 | Output 1.3 Management | ||
| 2026-01-31 | Expenditure | USD 2,105 | Output 1.3 Management | ||
| 2026-01-31 | Incoming funds | USD 4,820 | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-01-31 | Expenditure | USD 42k | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-01-31 | Incoming funds | USD 4,583 | Output 1.4 Monitoring and Evaluation | ||
| 2026-01-31 | Expenditure | USD 0 | Output 1.4 Monitoring and Evaluation | ||
| 2026-01-31 | Incoming funds | USD 16k | Output 2.1 Strengthened Coordination an | ||
| 2026-01-31 | Expenditure | USD 16k | Output 2.1 Strengthened Coordination an | ||
| 2026-01-31 | Incoming funds | USD 15k | Output 2.2 Building Capacity for industr | ||
| 2026-01-31 | Expenditure | USD 16k | Output 2.2 Building Capacity for industr | ||
| 2026-01-31 | Incoming funds | USD 1,125 | Output 1.2: Enhanced manufacturing | ||
| 2026-01-31 | Expenditure | USD 1,243 | Output 1.2: Enhanced manufacturing | ||
| 2026-02-28 | Incoming funds | USD 0 | Output 2.2 Building Capacity for industr | ||
| 2026-02-28 | Expenditure | USD 816 | Output 2.2 Building Capacity for industr | ||
| 2026-02-28 | Incoming funds | USD 0 | Output 2.1 Strengthened Coordination an | ||
| 2026-02-28 | Expenditure | USD 88 | Output 2.1 Strengthened Coordination an | ||
| 2026-02-28 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2026-02-28 | Expenditure | USD 1 | Output 1.2: Enhanced manufacturing | ||
| 2026-02-28 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-02-28 | Expenditure | USD 449 | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-02-28 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2026-02-28 | Expenditure | USD 60 | Output 1.3 Management | ||
| 2026-03-31 | Incoming funds | USD 0 | Output 2.1 Strengthened Coordination an | ||
| 2026-03-31 | Expenditure | USD 51k | Output 2.1 Strengthened Coordination an | ||
| 2026-03-31 | Incoming funds | USD 443 | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-03-31 | Expenditure | USD 26 | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-03-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2026-03-31 | Expenditure | USD 38 | Output 1.3 Management | ||
| 2026-03-31 | Incoming funds | USD 0 | Output 2.2 Building Capacity for industr | ||
| 2026-03-31 | Expenditure | USD 47k | Output 2.2 Building Capacity for industr | ||
| 2026-03-31 | Incoming funds | USD -443 | Output 1.2: Enhanced manufacturing | ||
| 2026-03-31 | Expenditure | USD 185 | Output 1.2: Enhanced manufacturing | ||
| 2026-04-30 | Incoming funds | USD 0 | Output 2.1 Strengthened Coordination an | ||
| 2026-04-30 | Expenditure | USD 19k | Output 2.1 Strengthened Coordination an | ||
| 2026-04-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2026-04-30 | Expenditure | USD 0 | Output 1.3 Management | ||
| 2026-04-30 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-04-30 | Expenditure | USD 2 | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-04-30 | Incoming funds | USD 0 | Output 2.2 Building Capacity for industr | ||
| 2026-04-30 | Expenditure | USD 18k | Output 2.2 Building Capacity for industr | ||
| 2026-04-30 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2026-04-30 | Expenditure | USD 4,991 | Output 1.2: Enhanced manufacturing | ||
| 2026-05-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2026-05-31 | Expenditure | USD 247 | Output 1.3 Management | ||
| 2026-05-31 | Incoming funds | USD 0 | Output 2.2 Building Capacity for industr | ||
| 2026-05-31 | Expenditure | USD 921 | Output 2.2 Building Capacity for industr | ||
| 2026-05-31 | Incoming funds | USD 0 | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-05-31 | Expenditure | USD -2 | Output 1.1: Pharmaceutical ecosystem | ||
| 2026-05-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2026-05-31 | Expenditure | USD -58 | Output 1.2: Enhanced manufacturing | ||
| 2026-05-31 | Incoming funds | USD 0 | Output 2.1 Strengthened Coordination an | ||
| 2026-05-31 | Expenditure | USD 978 | Output 2.1 Strengthened Coordination an | ||
| 2026-06-30 | Incoming funds | USD 0 | Output 2.2 Building Capacity for industr | ||
| 2026-06-30 | Expenditure | USD 3,107 | Output 2.2 Building Capacity for industr | ||
| 2026-06-30 | Incoming funds | USD 0 | Output 2.1 Strengthened Coordination an | ||
| 2026-06-30 | Expenditure | USD 5,518 | Output 2.1 Strengthened Coordination an | ||
| 2026-06-30 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2026-06-30 | Expenditure | USD 306 | Output 1.2: Enhanced manufacturing | ||
| 2026-06-30 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2026-06-30 | Expenditure | USD 14 | Output 1.3 Management | ||
| 2026-07-31 | Incoming funds | USD 0 | Output 1.4 Monitoring and Evaluation | ||
| 2026-07-31 | Expenditure | USD 27k | Output 1.4 Monitoring and Evaluation | ||
| 2026-07-31 | Incoming funds | USD 0 | Output 2.2 Building Capacity for industr | ||
| 2026-07-31 | Expenditure | USD 20k | Output 2.2 Building Capacity for industr | ||
| 2026-07-31 | Incoming funds | USD 0 | Output 2.1 Strengthened Coordination an | ||
| 2026-07-31 | Expenditure | USD 29k | Output 2.1 Strengthened Coordination an | ||
| 2026-07-31 | Incoming funds | USD 0 | Output 1.3 Management | ||
| 2026-07-31 | Expenditure | USD 871 | Output 1.3 Management | ||
| 2026-07-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2026-07-31 | Expenditure | USD -1,039 | Output 1.2: Enhanced manufacturing | ||
| 2026-08-31 | Incoming funds | USD 0 | Output 1.4 Monitoring and Evaluation | ||
| 2026-08-31 | Expenditure | USD 153 | Output 1.4 Monitoring and Evaluation | ||
| 2026-08-31 | Incoming funds | USD 0 | Output 1.2: Enhanced manufacturing | ||
| 2026-08-31 | Expenditure | USD 851 | Output 1.2: Enhanced manufacturing | ||
| 2026-08-31 | Incoming funds | USD 0 | Output 2.1 Strengthened Coordination an | ||
| 2026-08-31 | Expenditure | USD 695 | Output 2.1 Strengthened Coordination an | new | |
| 2026-08-31 | Incoming funds | USD 0 | Output 2.2 Building Capacity for industr | ||
| 2026-08-31 | Expenditure | USD 162 | Output 2.2 Building Capacity for industr | new | |
| 2026-09-30 | Incoming funds | USD 0 | Output 2.1 Strengthened Coordination an | new | |
| 2026-09-30 | Expenditure | USD 7,208 | Output 2.1 Strengthened Coordination an | new | |
| 2026-09-30 | Incoming funds | USD 0 | Output 2.2 Building Capacity for industr | new | |
| 2026-09-30 | Expenditure | USD 2,514 | Output 2.2 Building Capacity for industr | new | |
| 2026-09-30 | Incoming funds | USD 0 | Output 1.4 Monitoring and Evaluation | new | |
| 2026-09-30 | Expenditure | USD 207 | Output 1.4 Monitoring and Evaluation | new | |
| 2026-08-31 | Expenditure | USD 162 | Output 2.2 Building Capacity for industr | removed | |
| 2026-08-31 | Expenditure | USD 694 | Output 2.1 Strengthened Coordination an | removed |
Struck-through rows were in the previous version, last seen 2026-10-01 02:30 UTC, and are not in the current file.